The dramatic increase in the complexity of flow cytometric datasets requires the development of new computational based approaches that can maximize the amount of information derived and overcome the limitations of traditional gating strategies. Herein, we present a multivariate computational analysis of the HIV-infected flow cytometry datasets that were provided as part of the FlowCAP-IV Challenge using unsupervised and supervised learning techniques. Out of 383 samples (stimulated and unstimulated), 191 samples were used as a training set (34 individuals whose disease did not progress, and 157 individuals whose disease did progress). Using the results from the training set, the participants in the Challenge were then asked to predict the condition and progression time of the remaining individuals (45 'non-progressors' and 147 'progressors'). To achieve this, we first scaled down data resolution. We then excluded doublet cells from the analysis using Expectation Maximization approaches. We then standardized all samples into histograms and used Genetic AlgorithmNeural Network to extract feature sets from the datasets, the reliability of which were examined using WEKA-implemented classifiers. The selected feature set resulted in a high sensitivity and specificity for the discrimination of progressors and non-progressors in the training set (average True Positive Rate = 1.00 and average False Positive Rate = 0.033). The capacity of the feature set to predict real-time survival time was better when using data from the 'unstimulated' training set (r = 0.825). The p-values and 95% confidence interval logrank ratios between actual and predicted survival time in the test set were 0.682 and 0.9542±0.24 for the unstimulated dataset, and 0.4451 and 0.9173±0.23 for the stimulated dataset. Our analytic strategy has demonstrated a promising capacity to extract useful information from complex flow cytometry datasets, despite a significance imbalance and variation between the training and test sets.
INTRODUCTION
Recent advances in instrumentation and data acquisition platforms have strengthened the potential of flow cytometry as a platform for clinical diagnosis and decision-making (1-3), drug discovery and drug development (4) (5) (6) . However, the ability to achieve this requires high-dimensional datasets and new approaches for the automated analysis of these. In order to stimulate progress in this area, the FlowCAP Consortium (7) has established a series of competitions, the aims of which are to promote the development of computational methods for automatically identifying cell populations in multi-dimensional flow cytometry data and therefore remove the need for 'subjective' manual gating. The recent competition (FlowCAP-IV) provided flow cytometry data on the phenotype of unstimulated peripheral blood mononuclear cells (PBMCs) from HIV infected individuals, and also of PBMCs that had been stimulated in vitro with HIV antigens. The aim of the contest was to use data from the provided 'training' samples which came from individuals with known outcomes (i.e. nonprogressor and progressor) and the survival time (in days) to identify which features within the cell populations which could be used to predict the time to progression to Acquired Immune Deficiency Syndrome (AIDS) and outcomes for those individuals whose data were provided in the 'test' set.
The analysis of the data in this competition presented 3 major challenges. Firstly, the data were highly imbalanced: the ratio of non-progressors to progressors was 1:4.6, and the mean survival time of patients varied widely (maximum = 5855 days, minimum = -10 days, mean 947.36 days). Secondly, the number of events that were captured in the non-progressor group ranged between 40131 and 1000000 (mean = 388598, standard deviation = 287653 and median = 335049, unstimulated and stimulated dataset combined) and events captured in the progressor group ranged between 12668 and 1000000 (mean = 281518, standard deviation = 239968 and median = 183671, unstimulated and stimulated dataset combined). Thirdly, the F o r P e e r R e v i e w 5 data exhibited high complexity, in that the cell profiles within the progressor and nonprogressor groups were irregular and the data was of a high resolution: the data has 262144 possible channels (equivalent to 18 bit ADCs). Standard computational techniques which assume equality of sample distribution and uniformity of cell distribution, are therefore not very effective for analyzing this dataset. Furthermore, a data pre-processing step which lowers the resolution of the data in order to improve the processing time of the algorithm and the analysis of the histograms, but without compromising the original characteristics of the data is required.
Taking into these challenges into consideration, we proposed a multivariate analysis strategy which would utilize the learning power of unsupervised and supervised learning principles to identify features within the histograms that have the capacity to predict / identify outcome and progression. In order to achieve this, we first scaled down the resolution of the data and used an unsupervised learning method called Expectation Maximization (EM) to remove doublet cells from analyzed cell populations. We then standardized the remaining live, singlet cells into histograms and applied a supervised learning method called Genetic Algorithm-Neural Network (GANN) to identify features that can differentiate non-progressor from progressor and predict the survival time of all patients. We term our method as EM/GANN since it makes use of 2 computing techniques to interpret flow cytometric data:
(a) doublet removal using EM clustering and (b) identification of feature sets using GANN.
The use of EM for the analysis of flow cytometry data is not new. The EM algorithm has been commonly used, in conjunction with statistical mixture models, to discover cell populations in samples. Several examples include optimized t-mixture model (8), the skew tmixture model in FLAME (9) and also in the mixture modeling approach which has been proposed by Boedigheimer and Ferbas (10). However, we did not use EM to optimize the GANN algorithm, rather we used the EM algorithm alone to discover singlet cells in the 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w   6 population and the GANN algorithm to identify feature sets that can describe the difference between non-progressors and progressors, and the survival time of the patients. GANN is the bespoke algorithm which has been designed for handling large-scale datasets (11).
This study did not analyze the flow cytometry data using the more typically applied gating and hierarchy-based approaches. As a consequence, rather than reporting on features on a 'population' basis (i.e. positive and negative populations for each marker or combination of markers), we examined the capacity of every feature within cell population (i.e. every channel in the histogram plot) to identify features that can (1) discriminate between nonprogressors and progressors, and (2) predict the survival time of HIV-infected patients. We will therefore report the identified feature on the basis of channel numbers -for example, IL2_5 represents the channel number 5 in histogram for IL2 expression. 
Data scaling
Given {1, 2,..., } x i ∈ is the cell events in which {1, 2,... } i is the relative intensity value and channel number of events, s is the scaling factor and d R is the reduced resolution channels. A simple equation is given as follows: 
In this study, we used 1024 channels (equivalent to 10 bit ADCs).
Doublet removal using EM
EM is an effective iterative procedure to produce Maximum Likelihood (ML)
estimates of unknown parameters when the outcomes of these parameters are clumped together (12,13). The EM algorithm contains 2 iterative steps: an expectation step (E-step) and a maximization step (M-step). The E-step computes an estimate for the unknown variables using the observed variables and current estimate of the parameters. In our study, the simple EM algorithm from the WEKA data mining suite (14), version 3.6 was used to cluster singlet cells from the cell populations. The default parameter setting was used, except that the number of clusters was set between 3 and 4, depending on the variability of background noise in the population. In the default setting, a 10 fold crossvalidation procedure and 0.0001 γ = were applied.
Histogram transformation
Cumulative 
Feature selection using GANN
GANN is the bespoke hybrid method of a genetic algorithm (GA) and an artificial neural network (ANN) which co-evolve together to find optimal set of features that, given a basic ANN classifier (i.e. feedforward neural network), will effectively classify the data (15).
GA is tasked with finding the optimum ANN with a feature set that will correctly discriminate the classes and ANN is tasked to optimize the fitness values of GA.
is the total number of samples in the dataset, ik s is the sample i in class k , ik T is the target output of the sample i in class k , ik A is the activation value of ANN, k C is the centroid value of class k and ik O is the final prediction value generated by ANN, fitness of GA is iteratively examined by ANNs in the following equation: 
For network activation function, ( ) f x , given w is the network weight, i is the input node to the hidden node j and b is the bias nodes, ( ) f x can be expressed as:
The remaining parameter was set as follows: Total repetitions = 1000, Population size = 100, Fitness evaluation = 40000, Input node = 10 and Hidden node = 5.
Classification using cost-sensitive classifier
Considering the degree of imbalance in the data, cost-sensitive classifiers (CSC), Figure 2 shows the gating results generated by EM in order to illustrate its elasticity for processing flow cytometry data. The plot of the original samples was depicted in Figure 1 .
RESULTS

Doublet removal
Using SSC-A, FSC-A and Time, most of the doublets and unwanted cells were eliminated from the subsequent analysis, thereby leaving singlet and "lymphocyte-like" cell populations. and number of events captured in each group, EM is able to cluster singlet cells from such cell populations.
Feature sets differentiating non-progressor from progressor
For the stimulated dataset, a total of 5 features (IL2_5, IL2_6, IL2_7, IL2_8 and IL2_9) were identified as being able to discriminate between non-progressors and progressors. For the unstimulated dataset, 7 features from 4 separate markers (CD154_5, CD154_6, CD45RO_1023, CCR7_9, IL2_6, IL2_7 and IL2_8) were deemed to be significant. Table 1 shows the summary results for the non-progressor group, and the misclassification cost for the group is presented in Figure 3 .
All of the 34 samples from the non-progressor group in the training set were perfectly
classified. An False Positive Rate (FPR) lower than 20% confirmed the predictive capacity of Table 2 ).
Significant variations in IL2_5 and IL2_6 in the stimulated samples and IL2_6 in the unstimulated samples in the training and test sets were detected, thereby indicating that these features might be associated with certain (training set) patients in the data. This led to the low TPR in the non-progressor group in the test set.
Feature sets to predict survival time of HIV patients
A total of 6 features from 4 markers (IL2_1, CD3_1, CD3_2, CD8_9, CD107A_6 and CD107A_7) and 7 features from CD45RO marker (CD45RO_16, CD45RO_17, CD45RO_18, CD45RO_19, CD45RO_22, CD45RO_23 and CD45RO_26) in unstimulated and stimulated datasets exhibited a strong capacity to predict real-time survival time of patients in the training set (r = 0.535 in the stimulated dataset and r = 0.825 in the unstimulated dataset) ( Table 3 ). The predictive capacity of these feature sets was significantly lower in the test sets (r = 0.149, stimulated and r = 0.173. unstimulated). This is not too surprising given that our regression model was trained using actual progression times of patients.
The capacity of these feature sets to predict patient survival times was evaluated using a log-rank (Mantel-Cox) test which was based on the actual and the predicted progression time for stimulated and unstimulated datasets was calculated and the survival plot based on these dataset is presented in Figure 4 . The p-values and 95% confidence interval log-rank ratios between actual and predicted survival time for stimulated data are 0.2956 and survival curve and the predicted survival curve in these datasets, and demonstrates that the selected feature sets are able to provide proximity prediction to the actual results.
Interestingly, the feature set identified from the unstimulated dataset has better prediction accuracy than the feature set selected from the stimulated dataset. 
CONCLUSIONS
We proposed a multivariate analysis strategy that assembles unsupervised and supervised learning principles to interpret complex flow cytometry data. We used EM and GANN to identify the capacity of individual features within fluorescence histograms to predict the outcome of patients with HIV (i.e. non-progressor and progressor) and their survival time (in days). The classification models based on these feature sets were trained using 191 training samples and validated using a separate set of data (192 test samples).
Fewer than 7 features (i.e. 5 features from stimulated and 7 features from unstimulated) have been shown to be able to discriminate non-progressors from progressors and to predict survival time of patients (6 features for the stimulated dataset and 7 features for the unstimulated dataset). The better performance of these feature sets in the training set than in the test set is likely due to the significant variation on these features between training and test sets. Somewhat counter-intuitively, features from the unstimulated dataset were better at predicting the survival time than the features identified from the stimulated dataset. In summary, we have developed a new approach for analyzing complex flow cytometry datasets which has the potential to extract features that have the capacity to predict disease progression and survival in patients with HIV infection. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
